Patents by Inventor Tracy Ann Willson

Tracy Ann Willson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Screening methods using SOCS box-containing peptides
    Patent number: 7078174
    Abstract: The present invention relates generally to amino acid sequences obtainable from SOCS proteins and which are capable of interacting with intracellular molecules. The present invention further relates to nucleic acid molecules encoding said amino acid sequences. The amino acid sequences and the nucleic acid molecules encoding same of the present invention are useful in modulating degradation of proteinaceous molecules such as but not limited to SOCS proteins and proteinaceous molecules associated therewith. The present invention provides a mechanism for modulating cytokine or cytokine-like molecule signalling by modulating the degradation of activated signal transduction molecules or their negative regulators, i.e. the SOCS proteins.
    Type: Grant
    Filed: December 21, 1999
    Date of Patent: July 18, 2006
    Assignee: The Walter & Eliza Hall Institute of Medical Research
    Inventors: Tracy Ann Willson, Richard John Simpson, Alison Mary Farley, Sandra Elaine Nicholson, Jian-Guo Zhang, Manuel Baca, Nicos A. Nicola, Douglas J. Hilton, Warren Scott Alexander, Donald Metcalf
  • Leukaemia inhibitory factor
    Publication number: 20030004098
    Abstract: The present invention provides isolated DNA molecules encoding human and murine LIF and methods of producing LIF by the expression of the isolated DNA in suitable host cells. The invention further provides human and murine LIF polypeptides, pharmaceutical compositions containing LIF, and methods of use thereof.
    Type: Application
    Filed: February 12, 2001
    Publication date: January 2, 2003
    Inventors: David Paul Gearing, Nicholas Martin Gough, Douglas James Hilton, Julie Ann King, Donald Metcalf, Edouard Collins Nice, Nicos Anthony Nicola, Richard John Simpson, Tracy Ann Willson
  • Leukaemia inhibitory factor
    Patent number: 6261548
    Abstract: The present invention provides isolated DNA molecules encoding human and murine LIF and methods of producing LIF by the expression of the isolated DNA and suitable host cells. The invention further provides human and murine LIF polypeptides, pharmaceutical compositions containing LIF, and methods of use thereof.
    Type: Grant
    Filed: April 21, 1997
    Date of Patent: July 17, 2001
    Assignee: Amrad Corporation Limited
    Inventors: David Paul Gearing, Nicholas Martin Gough, Douglas James Hilton, Julie Ann King, Donald Metcalf, Edouard Collins Nice, Nicos Anthony Nicola, Richard John Simpson, Tracy Ann Willson
  • Leukaemia inhibitory factor
    Patent number: 5750654
    Abstract: The present invention provides isolated DNA molecules encoding human and murine LIF, and methods of producing LIF by the expression of the isolated DNA in suitable host cells. The invention further provides human and murine LIF polypeptides, pharmaceutical compositions containing LIF, and methods of use thereof.
    Type: Grant
    Filed: March 29, 1995
    Date of Patent: May 12, 1998
    Assignee: Amrad Corporation Limited
    Inventors: David Paul Gearing, Nicholas Martin Gough, Douglas James Hilton, Julie Ann King, Donald Metcalf, Edouard Collins Nice, Nicos Anthony Nicola, Richard John Simpson, Tracy Ann Willson